MediciNova Inc.

MNOV | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.30

-$0.02 (-0.60%)

At close: Sep 21, 2026, 4:00 PM ET

$3.26

-$0.04 (-1.25%)

Pre-market: Sep 22, 2026, 8:44 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.60%

(1D)

Rating

Updated: Sep 18, 2026

32.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $162.43M

1D Range

3.05 3.31

52W Range

1.17 3.90

Valuation (TTM)

PE -15

PB 0.00

EV/EBITDA 2,978.24

Valuation (NTM)

Forward PE N/A

Forward PEG -0.20

Price Target $6

Cash Flow

FCF Yield -3327.5%

SBC Adj. FCF Yield -3687.5%

SBC Impact -10.8%

Margins

Gross Margin 42.4%

Operating Margin -2.0%

FCF Margin -1177.8%

Growth (CAGR)

Revenue 3Y | 5Y 149.3% | 158.2%

Dil EPS 3Y | 5Y -11.9% | 4.8%

FCF 3Y | 5Y -149.3% | -98.9%

Returns

ROA -26.6%

ROE -26.5%

ROIC -31.5%

Financial Health

Net Cash

$25.3B

Current Ratio 8.75

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

MediciNova, Inc. is a biopharmaceutical firm dedicated to discovering and advancing innovative small molecule therapies for severe illnesses where current treatments are insufficient within the United...

Sector Healthcare

Industry Biotechnology

Employees 6

IPO Date Dec 7, 2006

Website www.medicinova.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 12, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+81.82%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞